J. Walter Thompson last week won creative duties outside the U.S. on an unnamed new incontinence drug to be co-marketed by Boehringer Ingelheim and Eli Lilly & Co., sources said. The other finalists for the estimated $25 million assignment were Omnicom’s BBDO in Dusseldorf, Germany; IPG’s Foote Cone & Belding in New York; and Havas’ Euro RSCG Life in London, said sources. JWT’s London office will likely manage the account.
Get Adweek's Brand Marketing Daily Newsletter in your Inbox
Today's highs and lows of creativity